Cargando…
Serum cytokine levels of COVID-19 patients after 7 days of treatment with Favipiravir or Kaletra
BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that causes coronavirus disease 2019 (COVID-19) has infected 86,4 M patients and resulted in 1,86 M deaths worldwide. Severe COVID-19 patients have elevated blood levels of interleukin-6 (IL-6), IL-1β, tumor necrosis factor (TN...
Autores principales: | Mortaz, Esmaeil, Bassir, Ali, Dalil Roofchayee, Neda, Dezfuli, Neda K., Jamaati, Hamidreza, Tabarsi, Payam, Moniri, Afshin, Rezaei, Mitra, Mehrian, Payam, Varahram, Mohammad, Marjani, Majid, Mumby, Sharon, Adcock, Ian M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7826095/ https://www.ncbi.nlm.nih.gov/pubmed/33631512 http://dx.doi.org/10.1016/j.intimp.2021.107407 |
Ejemplares similares
-
Potential diagnostic value of pleural fluid cytokines levels for tuberculous pleural effusion
por: Dalil Roofchayee, Neda, et al.
Publicado: (2021) -
Increased Serum Levels of Soluble TNF-α Receptor Is Associated With ICU Mortality in COVID-19 Patients
por: Mortaz, Esmaeil, et al.
Publicado: (2021) -
Evaluation of Lymphocyte Subtypes in COVID-19 Patients
por: Rezaei, Mitra, et al.
Publicado: (2022) -
T Helper Cell Subsets in the Pleural Fluid of Tuberculous Patients Differentiate Patients With Non-Tuberculous Pleural Effusions
por: Roofchayee, Neda Dalil, et al.
Publicado: (2021) -
NRITLD Protocol for the Management of Outpatient Cases of COVID-19
por: Rezaei, Mitra, et al.
Publicado: (2021)